Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;23 Suppl 4(Suppl Suppl 4):44-49.
doi: 10.1111/nep.13465.

Salt, water and nephron: Mechanisms of action and link to hypertension and chronic kidney disease

Affiliations
Review

Salt, water and nephron: Mechanisms of action and link to hypertension and chronic kidney disease

Qi Qian. Nephrology (Carlton). 2018 Oct.

Abstract

Our knowledge on sodium and water homeostasis and regulation continues to evolve. A considerable amount of new information in this area has emerged in recent years. This review summarizes existing and new literature and discusses complex multi-organ effects of high-salt and low-water intake and role of arginine vasopressin in this process, as well as the potential clinical significance of non-osmotic sodium storage pool and rhythmicity of urine sodium excretion. It has become clear that sodium and water dysregulation can exert profound effects on kidney and vascular health, far greater than previously recognized. Maladaptation to a combined high-salt and low-water intake can be linked to the growing epidemic of hypertension and chronic kidney disease.

Keywords: arginine vasopressin (AVP); chronic kidney disease (CKD); hypertension; non-osmotic pool of sodium; salt and water regulation; skin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) and (B) Arginine vasopressin (AVP)‐mediated intraglomerular hypertension (HTN), a consequence of combined afferent vasodilation (modulation of tubuloglomerular feedback, TGF) and efferent vasoconstriction (activation of renin angiotensin‐aldosterone system, RAAS). AVP positively influences renal sodium absorption at the levels of thick‐ascending limb and distal tubules. It also increases urea cycling and intramedullary urea retention by upregulating urea transporters A1 (UT‐A1) and A3 (UT‐A3) expression. (C) AVP V2 receptor‐mediated regulation of aquaporin 2 (AQP2) and ENaC. Additionally, hypertonicity of extracellular fluids can efficiently activate tonicity response element binding protein (TonEBP) which upregulates AQP2 expression (independent of AVP). TonEBP also upregulates the expression of osmoprotective genes in the renal epithelial cells, critical in preserving medullary structural integrity.
Figure 2
Figure 2
Combined effects of high‐salt and low‐water intake and their link to hypertension (HTN) and kidney dysfunction.

References

    1. Christ‐Crain M, Fenske W. Copeptin in the diagnosis of vasopressin‐dependent disorders of fluid homeostasis. Nat. Rev. Endocrinol. 2016; 12: 168–76. - PubMed
    1. Torres VE. Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu. Rev. Med. 2015; 66: 195–210. - PubMed
    1. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 2006; 52: 112–9. - PubMed
    1. Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL. Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin. Sci. (Lond.) 2009; 116: 257–63. - PubMed
    1. Gizowski C, Zaelzer C, Bourque CW. Clock‐driven vasopressin neurotransmission mediates anticipatory thirst prior to sleep. Nature 2016; 537: 685–8. - PubMed

MeSH terms

Substances